Employees Provident Fund Board’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.4M | Buy |
320,300
+70,300
| +28% | +$6.15M | 0.17% | 55 |
|
|
2026
Q1 | $21.3M | Sell |
250,000
-17,100
| -6% | -$1.52M | 0.16% | 54 |
|
|
2025
Q4 | $21.1M | Buy |
267,100
+8,199
| +3% | +$643K | 0.16% | 56 |
|
|
2025
Q3 | $20.7M | Buy |
258,901
+901
| +0.3% | +$76.9K | 0.17% | 60 |
|
|
2025
Q2 | $23.5M | Buy |
258,000
+55,306
| +27% | +$5.05M | 0.2% | 62 |
|
|
2025
Q1 | $19M | Buy |
202,694
+30,394
| +18% | +$2.72M | 0.22% | 61 |
|
|
2024
Q4 | $15.7M | Buy |
+172,300
| New | +$16.4M | 0.19% | 60 |
|
|
2023
Q3 | – | Sell |
-38,963
| Closed | -$3M | – | 81 |
|
|
2023
Q2 | $3M | Sell |
38,963
-55,047
| -59% | -$4.26M | 0.07% | 78 |
|
|
2023
Q1 | $7.06M | Buy |
94,010
+68,210
| +264% | +$5.07M | 0.18% | 63 |
|
|
2022
Q4 | $2.03M | Buy |
+25,800
| New | +$1.93M | 0.06% | 72 |
|
|
2018
Q4 | – | Sell |
-220,408
| Closed | -$14.8M | – | 65 |
|
|
2018
Q3 | $14.8M | Sell |
220,408
-330,260
| -60% | -$22M | 0.41% | 45 |
|
|
2018
Q2 | $35.7M | Buy |
550,668
+362,614
| +193% | +$23.7M | 0.97% | 37 |
|
|
2018
Q1 | $13.5M | Sell |
188,054
-69,946
| -27% | -$5.03M | 0.4% | 45 |
|
|
2017
Q4 | $19.5M | Hold |
258,000
| – | – | 0.52% | 44 |
|
|
2017
Q3 | $18.8M | Hold |
258,000
| – | – | 0.53% | 43 |
|
|
2017
Q2 | $19.1M | Sell |
258,000
-429,138
| -62% | -$31.9M | 0.55% | 46 |
|
|
2017
Q1 | $50.3M | Sell |
687,138
-12,764
| -2% | -$893K | 1.47% | 28 |
|
|
2016
Q4 | $45.8M | Buy |
699,902
+137,579
| +24% | +$9.43M | 1.57% | 29 |
|
|
2016
Q3 | $41.7M | Hold |
562,323
| – | – | 1.48% | 29 |
|
|
2016
Q2 | $41.2M | Buy |
562,323
+159,337
| +40% | +$11.3M | 1.75% | 25 |
|
|
2016
Q1 | $28.5M | Sell |
402,986
-350,103
| -46% | -$23.3M | 1.22% | 27 |
|
|
2015
Q4 | $50.2M | Sell |
753,089
-225,514
| -23% | -$15M | 1.72% | 22 |
|
|
2015
Q3 | $62.1M | Buy |
978,603
+55,463
| +6% | +$3.62M | 2.36% | 17 |
|
|
2015
Q2 | $60.4M | Sell |
923,140
-214,940
| -19% | -$14.6M | 2.11% | 19 |
|
|
2015
Q1 | $78.9M | Sell |
1,138,080
-40,099
| -3% | -$2.77M | 2.68% | 17 |
|
|
2014
Q4 | $81.5M | Buy |
1,178,179
+341,480
| +41% | +$23.1M | 2.49% | 18 |
|
|
2014
Q3 | $54.6M | Buy |
836,699
+61,207
| +8% | +$4.04M | 1.72% | 25 |
|
|
2014
Q2 | $52.9M | Buy |
775,492
+456,180
| +143% | +$30.6M | 1.67% | 26 |
|
|
2014
Q1 | $19.6M | Buy |
319,312
+137,977
| +76% | +$8.69M | 0.63% | 41 |
|
|
2013
Q4 | $11.8M | Sell |
181,335
-123,908
| -41% | -$7.93M | 0.36% | 46 |
|
|
2013
Q3 | $18.1M | Buy |
+305,243
| New | +$18.1M | 0.65% | 38 |
|
Other funds holding CL
Employees Provident Fund Board's CL Position: Q2 2026 in Review
Employees Provident Fund Board increased its Colgate-Palmolive (CL) stake by 28% in Q2 2026, buying an estimated $6.15M and bringing the position to 320,300 shares worth $29.4M. The position accounts for 0.17% of the portfolio, ranked #55.
Employees Provident Fund Board first reported a position in CL in Q3 2013 and has held it in 31 quarters since. The position peaked at $81.5M in Q4 2014. 2,002 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Employees Provident Fund Board held 320,300 shares of Colgate-Palmolive worth $29.4M as of Q2 2026.
- Employees Provident Fund Board bought 70,300 Colgate-Palmolive shares in Q2 2026, an estimated $6.15M.
- Colgate-Palmolive made up 0.17% of Employees Provident Fund Board's portfolio in Q2 2026, its #55 holding.
- Employees Provident Fund Board first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 31 quarters since.
- Employees Provident Fund Board's Colgate-Palmolive position peaked at $81.5M in Q4 2014.
- 2,002 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.